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Summary 
T cells bearing the T cell receptor ot//$ (TCR-cdB) are the predominant lymphocyte population 
in the human intestinal epithelium. To examine if normal intestinal intraepithdial lymphocytes 
(IEL) have a TCR repertoire distinct from the TCR-cffB repertoire in peripheral blood lymphocytes 
(PBL), comparative analysis of relative VB gene usage in IEL and PBL was performed by quantitative 
polymerase chain reaction.  In each of the six individuals examined,  one to three V/~ families 
made up more than 40% of the total V/$ transcripts  detected in the IEL, whereas there was 
a more even distribution of V/$ gene usage in the paired PBL. The predominant V/$ families, 
especially VB1, V/~2, V/~3, and V~6, were frequently shared among IEL of different individuals. 
PCR cloning and sequence analysis of the predominant V/86 family in two individuals revealed 
an identical V-D-J-C sequence in 13 of 21 dones obtained from one donor, and a different repeated 
sequence in 18 of 27 clones examined in the second donor. These data suggest that the V/~ skewing 
in IEL is due to an oligoclonal T cell expansion and may reflect the response of the intestinal 
mucosal immune system to a restricted  set of as yet undefined antigens present  in the gut. 
ttle  is  known about  the  function of lymphocytes  at 
epithelial  sites. Intestinal intraepithelial  lymphocytes 
(IEL)  1 are a predominantly CD4- 8 + subset of T cells local- 
ized throughout the epithelial lining of the gut (1). In the 
mouse, the majority of lymphocytes at epithelial surfaces such 
as the intestine use the TCR-3,/& Murine 3'/8 IEL express 
two major TCR V3"/V8  pairs (V3'5/V~4,6)  and have exten- 
sive  junctional diversity. As in the mouse, human TCR-3'/8 
cells preferentially localize within the gut epithelium rather 
than in the lamina propria.  However, the dramatic numer- 
ical epithelial predominance of 3,/8 cells in mice (50-75 % 
of the total IEL population) has not been observed in humans, 
where 3,/8 T cells make up *10% (range, 5-20%) of small 
bowel IEL and, according to one recent report, 37% (range, 
13-87%) of large intestine IEL (2, 3). Thus, the majority 
of T  cells in the adult human gut epithdium express the 
TCR-a/~ 
1  Abbreviaa'ons used in this paper: IEL, intraepithelial lymphocytes; LPL, 
lamina propria lymphocyte*. 
The peripheral TCK-ot//$ repertoire is the result of a com- 
plex selection process in the thymus involving the recogni- 
tion of sdf-MHC molecules (4). Alternatively, intestinal ep- 
ithelial cells may share some differentiation-inducing capacities 
with thymic epithelial ceils, leading to in situ TCR rearrange- 
ments on extrathymically  derived IEL, as suggested by re- 
cent evidence of an extrathymic pool of TCR-a//$ IEL in 
the routine gut (5). In addition to thymic and extrathymic 
sdection, a skewed TCK-odB repertoire  may result from 
microbial or food antigen-driven expansion of intestinal lym- 
phocytes. Evidence for the importance of TCR-od/~ IEL in 
response to intestinal microorganisms is found in mice, where 
colonization by normal intestinal flora has little effect on TCR- 
3'/8 IEL, but sharply increases the number of TCR-odB IEL 
(6). These findings suggest that T cells bearing TCR-od~s 
may play the predominant immunological role in the human 
gut epithelium. 
Here, the nature of the TCR repertoire of the predomi- 
nant cr  receptor in the human gut was examined. We found 
evidence for skewed V/~ gene usage and oligoclonality as major 
characteristics of this T  cell population. 
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Cell Isolation.  Human  colon samples and paired PBL were 
obtained  from adult  patients  undergoing  surgical resection  for 
colorectal carcinomas and, in one individual, for familial polyposis 
coli. Small bowel tissue was obtained from a normal individual after 
a terminal traumatic  event. IEL and lamina propria lymphocytes 
(LPL) were isolated from intestinal  sections at least 10 cm away 
from any macroscopically detectable lesions, as previously described 
(3). Four of the five colon samples were obtained from German 
donors;  the fifth colon sample as well as the small bowel sample 
were obtained from American  subjects. 
MonoclonalAntibodies.  Freshly isolated cells were stained with 
mAbs Leu-4, Leu-3, and Leu-2a (anti-CD3,  anti-CD4, and anti- 
CD8c~, respectively; Becton Dickinson  & Co., Mountain  View, 
CA), BMA031 (anti-TCR-~/~; Behringwerke, Marburg, Germany), 
j~F1 and TCR-gl (anti-TCR-a/~  and anti-CaS; T Cell Sciences, Cam- 
bridge,  MA), HML-1 (directed to a molecule expressed on many 
epithelial lymphocytes, including 90% of IEL [1]), and 2ST8.5H7 
(anti-CD8~ [7]). mAbs LC4 (anti-VB5.1), 1C1 (anti-Vi85.2 and 
V/35.3),  16G8 (directed  to members  of the VB8 family),  $511 
(directed to members of the V~12 family), and OT145 (anti-VB6.7a 
[8]) were obtained  from T  Cell Sciences. 
Immunofluorescence  and Flow Cytoraetry.  Flow cytometric two- 
color analyses, carried out as described (9), showed that c~/~ T 
cells made up 92% or more of the CD3 + cells in PBL, 77-98% 
in LPL, and 92-27% in IEL (32% in donor 1, 87% in donor 2, 
27% in donor 3, 79% in donor 4, 92% in donor 5, and 88% in 
donor 6). Cell preparations were adequately pure, since the frac- 
tion of HML-1 + cells was ~.90% or <0.5% in all IEL and PBL 
samples, respectively, and the CD4/CD8 ratio was <0.1 in IEL, 
>2.2 in LPL, and ~1.6 in PBL. 
Immunohistochemis~.  Frozen sections of colon tissue from donor 
2 were stained by the avidin-biotin complex method as reported 
(10). Reliability of the staining pattern for the different mAbs was 
monitored by staining of human thymus, tonsil, and lymph node. 
Quantitation of stained IEL was performed by differentially  counting 
the positive lymphocytes and the epithelial cells in a blinded fashion, 
and was expressed as the number of stained lymphocytes/100 epi- 
thelial ceils. More than 1,000 epithelial calls were counted in each 
tissue section stained. The exact binomial 95% confidence interval 
around the observed values was calculated, assuming uniform and 
random distribution of lymphocytes in adjacent tissue slices. Quan- 
titation  of stained lymphocytes in the tonsil sections, which in- 
cluded both T  cell areas and B cell follicles, was performed  by 
counting all positively stained lymphocytes with a reticular grid 
and calculating  the results as the number of ceils per mmL 
Polyraerase  Chain Reaction.  Isolation of total RNA, eDNA syn- 
thesis (from '~3/~g of total RNA), and PCR reactions were per- 
formed as described (9). Oligonucleotide  primers included a panel 
of 22 V~specific oligomers (corresponding to 20 VB families ana- 
lyzed) and one of two antisense oligomers from the downstream 
Q3 region.  Combined, these oligonucleotides  have been shown 
to detect  ,~90%  of the human V~ genes (11). Sense and anti- 
sense Ca primers (5'CCAGAACCCTGACCCTGCCGTG 3' and 
5'TATGGA_q~CGAGC~AGCACAGCK2TGTCTT 3') were used to 
amplify and quantitate  total  Cc~ eDNA in all samples, eDNA 
samples were diluted before quantitative PCR amplification so that 
comparable amounts  of Cc~, as well as a linear phase of Cc~ and 
V~ amplification, were obtained after 28 cycles  in each sample. For 
each individual,  analysis of PBL, LPL, and IEL were performed 
simultaneously and under identical conditions. PCK products were 
size separated on a 2% agarose gel, blotted onto Hybond-N (Amer- 
sham Corp.,  Arlington  Heights,  IL) membranes, and hybridized 
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with ~/-32p-labeled internal C~ probes (9), as well as an internal 
Ccr probe (5' TTTAGAGTCTCTCAGCTGGTA 3'). Results were 
visualized by autoradiography and quantified directly with a Beta- 
scope blot analyzer (Betagen Corporation,  Waltham,  MA). Most 
samples were analyzed at least twice, and results showed minimal 
variations. 
Validation of  Quantitative  PCR Analysis.  Quantitative PCK anal- 
yses were validated as described (9). In addition,  the percentage 
of TCR-~//5 cells (mAb BMA031 +) bearing  VBS.1, VB5.2/3, 
VB8, and VB12 was determined  in several PBL, LPL,  and IEL 
samples by two-color FACS  |  (Becton Dickinson & Co.) analyses 
using VB-specific  mAbs. Results correlated well with the quantita- 
tive PCR VB values, expressed as a percentage of the sum of all 
V~ transcripts measured. For example, the LPL sample of donor 
3 showed the following results (mAb staining vs. quantitative PCR): 
Vfl5.1, 4.9% vs. 5.4%; Vfl5.2/3, 3.0% vs. 2.9%; Vfl8, 7.7% vs. 
7.0%; Vf112, 4.0% vs. 1.5%. Quantitative PCR results throughout 
the study are therefore expressed as: percentage Vfl =  100x  (hy- 
bridization to one V~-specific PCR product/sum of all V~specific 
hybridizations); except in Fig. 2, where Vfl and Ca were coamplified 
within the same tube,  and Vfl usage was determined  relative to 
the total Cc~ expressed, using the formula: percentage Vfl =  100x 
(hybridization to one V~-specific PCIL product/total Ce-specific 
hybridization. 
Sequence Analysis of PCR-amplified PCR V~6 Transcripts.  VB6 
family-specific PCR amplification of eDNA from IEL and paired 
PBL of donor I and from IEL of donor 2 were performed. To en- 
sure the amplification of all members of the Vfl6 family, three Vfl6 
subfamily-specific oligonucleotides were used as sense primers in 
equal concentrations (V~6.1/2/3, 5' GACAGC~CTGAGGGATC- 
CGTCTC 3'; V~6.6/7, 5' GACAGGACTGGGC~ATCCGTCTC 
3'; and V~6.5/8/9,  5' GACAGGCCTAAGGGATCTTTCTC  3' 
The amplified products were directionally cloned into M13 vectors 
and sequenced by the dideoxy chain termination  method as previ- 
ously reported  (9). 
Results and Discussion 
Samples from five individuals were available for compara- 
tive study of PBL and colon-derived IEL and LPL. Surpris- 
ingly, an unequal expression of Vfl families was detected in 
the IEL. Vfl6 dominated in donor 1 (39%o), in donor 2 (19%), 
in donor 3 (19%), and in donor 4 (23%). In addition to Vfl6, 
prominent Vfl families were Vfl2 and Vfl3 in donor 2 (15% 
each), Vfl3 in donor 3 (20%), and Vfll in donor 4 (15%). 
In a fifth donor, Vfl2 (27%) and Vfl3 (25%) again predomi- 
nated while Vfl6 was not increased (Fig. 1, solid bars). Thus, 
in each donor, one to three Vfl families predominated  and 
accounted for a mean of 43% of the total Vfl transcripts de- 
tected. This contrasted with the PBL, where Vfl expression 
was more evenly distributed over the different Vfl families 
(Fig. 1, hatched bars), in percentages similar to those shown 
in previous studies of PBL (9, 11). Interestingly, the predom- 
inant Vfl families (Vfll,  Vfl2, Vfl3, and Vfl6) in the IEL 
were shared by different individuals.  Besides the major in- 
creases in Vfll, Vfl2, Vfl3, and Vfl6, small increases  of Vfl 
products in IEL compared with PBL were also noted,  in- 
cluding Vfl5.1  and Vf119 in donor  1,  and Vfll0 in donor 
5 (Fig. 1). Vfl13.1 was high in several IEL samples, but was 
also a substantial percentage of the total Vfl transcripts  in 
the paired PBL samples. The Vfl repertoire of LPL closely 
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Figure 1.  Skewed  Vl~ gene segment usage in human IEL. Relative  V~ 
gene usage  in freshly  isolated colon-derived  IEL (solid bars) and paired PBL 
(hatched bars) from donors 1, 4, and 5, and in freshly isolated  jejunum- 
derived IEL from donor 6. VB family (member) usage was determined 
by quantitative PCK and expressed as a percentage of the sum of total 
V~ measured, as outlined in Materials and Methods. The axis represents 
the entire panel of TCR V~ gene segment(s) measured. 
matched that of the PBL or showed results intermediate to 
those of IEL and PBL (data not shown). This finding is con- 
sistent with the previously reported polyclonality of LPL (12). 
Since the above results were expressed as a percentage of 
the sum of all V~ transcripts detected, the possibility existed 
that the observed predominance of V131, Vfl2, V133, and V136 
in IEL was an apparent increase,  secondary to the presence 
of Vl3 families not detected by the pand of V~5 primers used. 
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Figure 2.  Vfl6.1/2/3 usage, expressed as a percentage of total Cc~ mea- 
sured, is increased in IEL compared with paired PBL. PCR analysis of 
relative VB6.1/2/3 expression in freshly isolated colon-derived  IEL (solid 
Mrs) and paired PBL (hatched bars) in donors 1-4. V~6.1/2/3 and total 
Ca products were coampWied  by mixing V156.1/2/3-C13 and C~x-Co~ 
primer pairs within the same  tube. The obtained  products (~220 and •470 
bp, respectively) were size separated and hybridized to internal C3 and 
Cot probes, as described in Materials and Methods. 
The measurement of total Ca would include transcripts from 
all c~/fl T cells present, induding those whose V~/genes might 
not have been detected.  Therefore,  additional experiments 
using quantitative PCK compared the VI3 transcripts  rela- 
tive to the total Ca transcripts obtained under identical con- 
ditions for IEL and PBL samples.  In a representative experi- 
ment,  V~56 and  total  Ca  products  from  IEL  and  PBL 
populations of donors 1-4, coamplified by mixing the V136.1/ 
2/3-CJ3 and the Ca-Ca primer pairs within the same tube, 
were compared. In contrast with the PBL populations where 
V136.1/2/3  transcripts  constituted 7-12%  of the total Ca 
transcripts,  the proportion  of V~6.1/2/3  in  the  IEL was 
25-36%  of the total Ca expressed (Fig.  2). Thus, whether 
the relative quantities of VI3 products detected by PCP, were 
compared with the sum of all Vf3 products measured, or to 
the total amount of TCR Ca transcripts,  V131, V132, V153, 
and V~6 families were found to be increased in IEL com- 
pared with PBL. 
In addition to the colon-derived IEL populations studied 
above, a small bowel preparation  from a healthy donor in 
whom no PBL were available for comparison was also exam- 
ined. Unequal expression ofVl3 gene segments in the jejunum- 
derived IEL was again noted, with V~6 (38%) as the pre- 
dominantly expressed Vi3 family (Pig. 1, donor 6). Analysis 
of a jejunum-derived IEL cell line from another healthy donor 
maintained in culture for 4 wk was also performed. This line 
expressed 80%  HMbl + cells and >90%  CD4-8 + cells at V#  N  D~I.1 
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Figure 3.  TCK VB6 junctional 
nucleotide sequences derived from 
PCR-amplified eDNA from IEL (a) 
and PBL  (b) of donor  1,  IEL  of 
donor 2 (c), and the corresponding 
amino acid sequence of the junc- 
tional regions (d) Of the predominant 
IEL clone in donors I and 2, Com- 
parable  amounts  of cDNA  from 
1  each source were PCR amplified, 
1  using a combination  of V~6.1/2/3, 
1  V86.5/8/9,  and  V86,6/7  sense 
1  primers  in  equal  concentrations. 
1  Obtained  sequences  are grouped  ac- 
1  cording  to  V/36  family member 
3  usage. Family members V86.2 and 
1  6.3; V~6.5, 6.8, and 6,9; and V36.6 
1 
1  and  6.7  cannot  be  distinguished 
1  based  on  the  sequences obtained 
1  (25). The number of dones carrying 
I  an identical sequence are shown on 
1  the right. Numbers in parentheses 
1  l  indicate the amount of nucleotides 
I  deleted  from  the  germline  se- 
quences. A  +  or -  sign indicates 
whether sequences are in or out of 
frame, respectively. The germline 
1  D~1.1 and DB2.1 are shown at the  1 
top (22). D segments were assigned 
z  arbitrarily,  based on the presence of 
1  four or more nucleotides  colinear  2 
with germline  D~  sequences.  In 
1  two instances, D~1.1 and D~2,1 ap- 
1  peared  to be used in  tandem.  In 
1  donor 1, the predominant IEL done 
18  used V36.2 (or 6.3) rearranged to 
J/31.1/C31. The predominant IEL 
clone in donor 2 used V36.7 rear- 
ranged to J32.5/C82. In contrast 
with the donal dominance in both 
IEL samples, the paired PBL sample 
of donor  1 contained few repeats. 
the time of analysis, and VB6 (31%) and VB8 (25%) made 
up the majority  of V~ expressed (data not shown). Thus, 
skewing of the TCIL-odB repertoire relative to that in PBL 
was noted both in small and large bowel IEL, in samples from 
healthy donors as well as macroscopically  normal bowel ob- 
tained from patients with malignant or premalignant lesions, 
and irrespective of the proportion of 3'//~ cells present (8-73 % ). 
Furthermore,  previous studies have shown that V/31, VB2, 
V~3, VB6, and V/~8 were not expressed at higher levels in 
the CD4-8 + compared with the CD4+8 -  PBL subsets (9, 
13). Thus, the V~ TCR skewing of IEL appears to be char- 
acteristic for the IEL in the gut rather than merely CD8 pheno- 
type related. 
V~ families have been classified into two dusters, based 
on structural characteristics, including the ability of members 
of cluster I, but not cluster II, to form a salt bridge between 
the amino acids at positions 64 and 86. With the exception 
of VB3, each of the predominant human IEL families (V/31, 
VB2, and V~/6), as ,,yell as V88, which was found to be preva- 
lent in the IEL cell line, are members of cluster I. Although 
other members of cluster I were not increased in human IEL, 
these data suggest some similarity with the situation in the 
chicken, where only VB gene products  of cluster  I are ex- 
pressed by intestinal lymphocytes (14). 
To assess whether the predominant VB families in the IEL 
population were expressed by donal, oligodonal, or poly- 
clonal cell populations, the nucleotide sequences of randomly 
isohted eDNA clones from PCR-ampliiied material of the 
most predominant V/9 family, V/96, were determined in two 
IEL and one PBL sample. Surprisingly,  a donal population 
60  Oligoclonality of Human Gut Intraepithdial  Lympbocytes Figure 4.  Predominant expression of V/~6.7 by IEL of donor 2 demon- 
strated by immunohistology. Staining of normal colonic mucosa of donor 
2 was performed with mAb ~F1 (anti-TCK-od~) (A), mAb OT145 (anti- 
V~6.7a) (B), and mAb LC4 (anti-V~5.1) (C). Control tonsil sections were 
stained with mAb OT145 (D) and mAb LC4 (E). Staining was performed 
using an avidin-biotin  comple~ method with 3-arnino-9-ethylcarbazole  as 
the substrate (10). Representative  fields of the tissue sections  ~ined 
are shown;  for the tonsil, interfollicular T cell areas are presented.  Lym- 
phocytes identified by the mAbs stained red in a peripheral pattern and 
are marked by arrows. E and LP indicate the epithelium and the lamina 
propria respectively. Note that several LPL also stained positive  with mAb 
EFt. 
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quences of donor 1, 13 sequences were identical, as were 18 
of 27 in-frame sequences of donor 2 (Fig.  3).  In contrast, 
the paired PBL sample of donor 1 showed a polyclonal popu- 
lation, with few repeats in the 19 clones sequenced.  Thus, 
the VB skewing in adult IEL appears to be caused by an 
oligodonal T cell expansion. The predominant clones in the 
two IEL populations were different, as V/~6.2 (or 6.3, as se- 
quences are identical in the region obtained) rearranged to 
J131.1/C/31 in donor 1, and V136.7 (6.7a, 6.7b, or 6.6) rear- 
ranged to JB2.5/C~2 in donor 2 (Fig. 3). VB6.2/3 and V/36.7 
differ in their first and second complementarity determining 
regions, as well as in the region shown to confer superan- 
tigen reactivity (15). The difference in V136 family member 
usage between the two individuals may thus reflect the in- 
teraction of these Vl3 products with distinct peptide/MHC 
complexes, or with distinct superantigens. Furthermore, the 
dissimilar junctional amino acid sequences and extensive junc- 
tional N  segment insertions and germline nucleotide dele- 
tions of the clonally expanded IEL TCR-13 sequences in the 
two donors suggest that the expanded IEL, unlike the mu- 
fine dendritic epidermal cells, are unique in each individual 
and are not derived from an early fetal stage (2, 16). Regarding 
the origin of adult TCR-cx/B IEL, two-color staining with 
CD8 mAbs revealed that the majority (70-95%) of the TCR- 
ot/~ IEL expressed CD8-od/3 heterodimers (data not shown). 
Thus, ff the type of CD8 co-receptor is indicative of the origin 
of IEL in humans, as has been suggested in the mouse (5), 
the majority of adult human TCR-odB IEL studied here ap- 
pear to be thymus derived. 
Some evidence for oligodonality in tumor-infiltrating lym- 
phocytes of nonintestinal tumors has been reported (17, 18). 
A relationship between the oligoclonality observed here and 
the presence of colorectal carcinoma in some of the patients 
cannot be totally excluded.  However,  the findings of VI3 
skewing in IEL of healthy donors, the previously reported 
absence of oligodonality in LPL of patients with colorectal 
carcinoma (12), and the substantial distance between the malig- 
nant lesions and the sections studied, make a causal relation- 
ship unlikely. 
We were able to confirm the predominant expression of 
V136.7 by  IEL  of donor 2  by performing immunohisto- 
chemistry using a VB6.7a-specific mAb (8). Staining of large 
bowel tissue of donor 2 with the V136.7a-specific mAb was 
compared with staining with V35.1, VB5.2/3, V138, VB12, 
as well as TCR-/3 and CD3-specific mAbs. On average, 2.6 
lymphocytes/100 epithelial cells and 2.8 lymphocytes/100 
epithelial cells stained with 3F1 and Leu-4 mAbs, respectively, 
consistent with the expected number of IEL in the large 
bowel (Fig. 4 A). Significantly,  an average of 1.2 lympho- 
cytes/100 epithelial cells or  *44%  of the TCR-od/3 IEL 
stained with the VB6.7a-specific mAb (95% confidence in- 
terval, 0.25-0.65), confirming the predominance of V36.7 
in this IEL sample (Fig.  4 B).  In contrast,  no IEL were 
identified in an area of >1,000 epithelial cells after staining 
with V35.1- (Fig. 4 C), VB5.2/3-, V138-, and V312-specific 
mAbs. The opposite result was seen in control tonsil tissue, 
where the V136.7 mAb identified proportionally fewer cells 
than did the other V~specific mAbs; for instance,  53 lym- 
phocytes/mm  2 and  158 lymphocytes/mm  a were identified 
after staining with the V/36.7a mAb and the V35.1 mAb, 
respectively (Fig. 4, D and E). The predominant staining of 
large bowel tissue of donor 2 with the V36.7a-specific mAb 
also contrasted sharply with the two-color FACS  |  analysis 
of his paired PBL sample, which showed that only 3% of 
the TCR-c~/3 cells stained positive with the V36.7a mAb. 
This is an intermediate level of VB6.7a usage in normal adult 
PBL (8,  13). 
Based on the data obtained here, we suggest that intes- 
tinal IEL, which are known to be CD45RO + (19), may be 
predominantly stimulated by conventional antigens, resulting 
in clonal expansion of the antigen-specific  T  cells. In vivo 
and in vitro, preferential expression of one V~8/JB  and Vot/Jot 
product with limited heterogeneity in the  junctional regions 
has been reported for T cells specific to cytochrome c, my- 
din basic protein, and myoglobin (20-22). Moreover, in long- 
term cultures of TNP-specific cytotoxic T cells, nearly half 
of the clones were found to use identical VB chain gene seg- 
ments including the V-D-J junctional region (23). Thus, con- 
tinuous stimulation by a small number of microbial antigens 
or self-stress antigens on intestinal epithelial cells might simi- 
larly lead to clonal proliferations of IEL. Whether antigen 
presentation predominantly occurs in Peyer's patches,  from 
where lymphoblasts recirculate  to the intestinal epithelium 
(1), or in the epithelium itself, by intestinal epithelial  cells 
(24),  remains to be determined. 
While superantigens are likely to contribute to the adult 
IEL repertoire, they would not alone be expected to result 
in the oligoclonal population detected here. Rather, they might 
give rise to a polyclonal population with high  junctional diver- 
sity while carrying the same VlJs (11, 15). However, a com- 
bination of superantigen-driven and conventional antigen- 
specific clonal expansions may result in the observed VB family 
predominance and oligoclonality of human IEL. 
In conclusion, this study demonstrates the existence of a 
site-specific and oligoclonal TCR-ot//3 repertoire in human 
gut epithelium. The oligoclonality of IEL points to the pres- 
ence of a restricted set of potent antigens in the gut that may 
be the ligands involved in the expansion of these T cells. Thus, 
the oligoclonality of IEL may be of major importance in 
providing an efficient immune response against these antigens. 
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